Cargando…

Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan

Prostate cancer is the most common genitourinary cancer in men. Population-based serum prostate-specific antigen (PSA) testing is used to screen men for the early detection of asymptomatic prostate cancer. The present study compared the features of patients with prostate cancer in Kusatsu City, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kageyama, Susumu, Okinaka, Yuki, Nishizawa, Koji, Yoshida, Toru, Ishitoya, Satoshi, Shichiri, Yasumasa, Kim, Chul Jang, Iwata, Tsuyoshi, Yokokawa, Ryusei, Arai, Yutaka, Nishikawa, Zenkai, Soga, Hiroki, Ushida, Hiroshi, Sakano, Yuji, Naya, Yoshio, Wada, Akinori, Nagasawa, Masayuki, Yoshida, Tetsuya, Narita, Mitsuhiro, Kawauchi, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756018/
https://www.ncbi.nlm.nih.gov/pubmed/36545210
http://dx.doi.org/10.3892/mco.2022.2599
_version_ 1784851541755166720
author Kageyama, Susumu
Okinaka, Yuki
Nishizawa, Koji
Yoshida, Toru
Ishitoya, Satoshi
Shichiri, Yasumasa
Kim, Chul Jang
Iwata, Tsuyoshi
Yokokawa, Ryusei
Arai, Yutaka
Nishikawa, Zenkai
Soga, Hiroki
Ushida, Hiroshi
Sakano, Yuji
Naya, Yoshio
Wada, Akinori
Nagasawa, Masayuki
Yoshida, Tetsuya
Narita, Mitsuhiro
Kawauchi, Akihiro
author_facet Kageyama, Susumu
Okinaka, Yuki
Nishizawa, Koji
Yoshida, Toru
Ishitoya, Satoshi
Shichiri, Yasumasa
Kim, Chul Jang
Iwata, Tsuyoshi
Yokokawa, Ryusei
Arai, Yutaka
Nishikawa, Zenkai
Soga, Hiroki
Ushida, Hiroshi
Sakano, Yuji
Naya, Yoshio
Wada, Akinori
Nagasawa, Masayuki
Yoshida, Tetsuya
Narita, Mitsuhiro
Kawauchi, Akihiro
author_sort Kageyama, Susumu
collection PubMed
description Prostate cancer is the most common genitourinary cancer in men. Population-based serum prostate-specific antigen (PSA) testing is used to screen men for the early detection of asymptomatic prostate cancer. The present study compared the features of patients with prostate cancer in Kusatsu City, the only municipality in Shiga Prefecture of Japan to implement organized PSA screening, with those in other municipalities. The target population for organized PSA screening by mail invitation was men ≥50 years. Patients were pathologically diagnosed via prostate biopsy because of elevated serum PSA. This multicenter observational study was subsequently conducted in 14 hospitals. The following information was extracted from patient records: age, reason for PSA testing, initial PSA level, Gleason score, clinical stage, and place of residence. Risk classification was defined as low, intermediate, high, and advanced. Each patient was stratified according to their city/town. A total of 984 patients diagnosed with prostate cancer in Shiga in 2012 and 2017 were analyzed, of which 955 (97%) were opportunistically tested, with the remaining 29 (3%) assessed by organized screening. In Kusatsu, 93 patients were diagnosed, of whom 26 (28%) were detected by organized screening. By contrast, only three of 891 patients (0.3%) were detected by organized screening in other municipalities. Of patients in Kusatsu, cases identified by opportunistic testing had a higher initial PSA value (P=0.010) than those identified by organized screening. However, patients detected through opportunistic testing in Kusatsu City were younger (P=0.034), had a lower PSA value (P=0.001), and improved risk classification (P<0.001) than those in other municipalities. It was concluded that more patients were diagnosed with early-stage cancer by organized PSA screening. Furthermore, population-based PSA screening in Kusatsu City may have indirectly affected early detection, even by opportunistic testing.
format Online
Article
Text
id pubmed-9756018
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-97560182022-12-20 Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan Kageyama, Susumu Okinaka, Yuki Nishizawa, Koji Yoshida, Toru Ishitoya, Satoshi Shichiri, Yasumasa Kim, Chul Jang Iwata, Tsuyoshi Yokokawa, Ryusei Arai, Yutaka Nishikawa, Zenkai Soga, Hiroki Ushida, Hiroshi Sakano, Yuji Naya, Yoshio Wada, Akinori Nagasawa, Masayuki Yoshida, Tetsuya Narita, Mitsuhiro Kawauchi, Akihiro Mol Clin Oncol Articles Prostate cancer is the most common genitourinary cancer in men. Population-based serum prostate-specific antigen (PSA) testing is used to screen men for the early detection of asymptomatic prostate cancer. The present study compared the features of patients with prostate cancer in Kusatsu City, the only municipality in Shiga Prefecture of Japan to implement organized PSA screening, with those in other municipalities. The target population for organized PSA screening by mail invitation was men ≥50 years. Patients were pathologically diagnosed via prostate biopsy because of elevated serum PSA. This multicenter observational study was subsequently conducted in 14 hospitals. The following information was extracted from patient records: age, reason for PSA testing, initial PSA level, Gleason score, clinical stage, and place of residence. Risk classification was defined as low, intermediate, high, and advanced. Each patient was stratified according to their city/town. A total of 984 patients diagnosed with prostate cancer in Shiga in 2012 and 2017 were analyzed, of which 955 (97%) were opportunistically tested, with the remaining 29 (3%) assessed by organized screening. In Kusatsu, 93 patients were diagnosed, of whom 26 (28%) were detected by organized screening. By contrast, only three of 891 patients (0.3%) were detected by organized screening in other municipalities. Of patients in Kusatsu, cases identified by opportunistic testing had a higher initial PSA value (P=0.010) than those identified by organized screening. However, patients detected through opportunistic testing in Kusatsu City were younger (P=0.034), had a lower PSA value (P=0.001), and improved risk classification (P<0.001) than those in other municipalities. It was concluded that more patients were diagnosed with early-stage cancer by organized PSA screening. Furthermore, population-based PSA screening in Kusatsu City may have indirectly affected early detection, even by opportunistic testing. D.A. Spandidos 2022-11-23 /pmc/articles/PMC9756018/ /pubmed/36545210 http://dx.doi.org/10.3892/mco.2022.2599 Text en Copyright: © Kageyama et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Kageyama, Susumu
Okinaka, Yuki
Nishizawa, Koji
Yoshida, Toru
Ishitoya, Satoshi
Shichiri, Yasumasa
Kim, Chul Jang
Iwata, Tsuyoshi
Yokokawa, Ryusei
Arai, Yutaka
Nishikawa, Zenkai
Soga, Hiroki
Ushida, Hiroshi
Sakano, Yuji
Naya, Yoshio
Wada, Akinori
Nagasawa, Masayuki
Yoshida, Tetsuya
Narita, Mitsuhiro
Kawauchi, Akihiro
Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan
title Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan
title_full Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan
title_fullStr Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan
title_full_unstemmed Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan
title_short Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan
title_sort population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in kusatsu city, shiga, japan
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756018/
https://www.ncbi.nlm.nih.gov/pubmed/36545210
http://dx.doi.org/10.3892/mco.2022.2599
work_keys_str_mv AT kageyamasusumu populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT okinakayuki populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT nishizawakoji populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT yoshidatoru populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT ishitoyasatoshi populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT shichiriyasumasa populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT kimchuljang populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT iwatatsuyoshi populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT yokokawaryusei populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT araiyutaka populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT nishikawazenkai populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT sogahiroki populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT ushidahiroshi populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT sakanoyuji populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT nayayoshio populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT wadaakinori populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT nagasawamasayuki populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT yoshidatetsuya populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT naritamitsuhiro populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan
AT kawauchiakihiro populationbasedprostatespecificantigenscreeningforprostatecancermayhaveanindirecteffectonearlydetectionthroughopportunistictestinginkusatsucityshigajapan